WM and COVID-19

On Friday 19 June, over 260 people joined our webinar, in partnership with Lymphoma Action, to hear our panel of UK experts answer some of the most commonly asked questions around COVID-19 and Waldenstrom’s macroglobulinaemia (WM). WMUK Chief Executive, Lindsey Bennister said “We hope that the webinar was useful for people affected by WM. Following the success of this first session, we are now looking to host further webinars around this and other topics relevant for people affected by WM. We would like to offer our sincere thanks to our panel of UK experts; Dr Shirley D’Sa and Helen DeMarco, our co-host Stephen Scowcroft and the team at Lymphoma Action, as well as everyone who participated in the webinar and submitted their questions to the panel in advance.